Innventure is an Orlando holding company that licenses technology out of multinationals and funds the ventures built to commercialise it. Nasdaq classifies it under Financial Services, industry Asset Management, and it employs 169 people. Plenty of readers will mistake it for an operating technology company. It is not one. The share price is not the interesting number here. The cash is: $55,367,000 on hand at 31 March 2026 against $34,031,000 of operating cash consumed in that single quarter, with a shelf registration effective since 8 April that carries a $75.0M standby equity purchase agreement. Second-quarter results land on 13 August.
Innventure, Inc. (NasdaqGM: INV) was founded in 2015 and is headquartered in Orlando, Florida. Its stated model is to identify, fund and operate companies built around sustainable technology acquired or licensed from multinational corporations. In practice it is a holding company: it takes technology that a large corporate has shelved, wraps a venture around it, funds that venture, and consolidates the result.
That structure matters more than any product story, because it dictates how the accounts behave. Revenue at the parent is $3,275,000. The reported quarterly earnings swing violently in both directions, and not because the operating business is volatile. A holding company books revaluations of its stakes, and those revaluations dwarf the trading. Nasdaq classifies the company under Financial Services, industry Asset Management, with 169 full-time employees. Anyone underwriting this as a cooling-technology company or a recycling company is underwriting the wrong entity.
The ventures themselves are real and are moving. Accelsius sells two-phase direct-to-chip cooling into data centres. Refinity is building plastics-to-olefins capacity and has licensed catalyst technology from Pacific Northwest National Laboratory. Both produced verifiable third-party milestones in June and July 2026. Neither yet produces the cash the parent consumes.
| Segment | Revenue | Description |
|---|---|---|
| Accelsius | not separately disclosed | Two-phase direct-to-chip liquid cooling for data centres. Independent benchmarks published 21 July 2026 showed 9°C lower NVIDIA B200 junction temperatures versus single-phase in warm-water conditions. |
| Refinity | not separately disclosed | Plastics-to-olefins conversion. Exclusive PNNL catalyst licence (22 June 2026) for converting olefins into circular hydrocarbon liquids for sustainable aviation fuel; Zeton appointed 23 July 2026 to design and build a modular plant. |
| Parent / other | $3.275M total company | Consolidated revenue for the whole group. Reported revenue growth of +544.2% is arithmetically true and analytically close to meaningless on a base this small. |
| Metric | Value | Signal |
|---|---|---|
| Cash and equivalents (31 Mar 2026) | $55,367,000 | 1.6 quarters |
| Operating cash used, Q1 2026 | -$34,031,000 | +39.7% vs Q4 2025 |
| Total debt | $26,705,000 | vs $55.4M cash |
| Revenue (TTM) | $3,275,000 | +544.2% |
| Enterprise value / revenue | 160.8x | EV $526.75M |
| EBITDA | -$94,825,000 | EV/EBITDA -5.6x |
| Return on equity | -47.4% | ROA -11.7% |
| Book value per share | $2.79 | P/B 1.23x |
| Shares outstanding | 84,044,748 | +69.6% since Nov 2024 |
| Q1 2026 net loss | -$27,783,000 | LPS -$0.27 |
| Quarter | EPS Actual | EPS Est. | Surprise | Revenue |
|---|---|---|---|---|
| Q2 2025 | $0.59 | $-0.17 | +$0.76 | - |
| Q3 2025 | $-0.44 | $-0.24 | -$0.20 | - |
| Q4 2025 | $0.01 | $-0.35 | +$0.36 | - |
| Q1 2026 | $-0.30 | $-0.34 | +$0.04 | - |
Two beats, one large miss, one small beat. Read the pattern, not the hit rate: a holding company that revalues its stakes will print a positive quarter without selling anything and a heavy negative one without losing a customer. Q2 2025 came in $0.76 above consensus and Q3 2025 landed $0.20 below it. Neither move told you anything about the ventures. — Next: 13 August 2026, Q2 2026. The line to read first is cash and equivalents, then net cash used in operating activities, then the share count on the cover page.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 20 Apr 2026 | Daniel J. Hennessy (Director) | sell | 582,139 | $3,213,407 at $5.52 |
| 14 Apr 2026 | Daniel J. Hennessy (Director) | sell | 2,992 | $14,990 at $5.01 |
| Oct–Dec 2025 | WE-INN LLC | sell | 3,100,513 across 14 filings | ≈$11.92M |
| 26 Nov 2025 | John Stewart Scott (Chief Strategy Officer) | sell | 452,668 | $2,322,187 at $5.13 |
| 2 Dec 2025 | Michael Otworth (Executive Chairman) | buy | 12,000 | $60,720 at $5.06 |
| 26 Nov 2025 | Gregory W. Haskell (CEO at the time) | buy | 10,000 | $51,400 at $5.14 |
| 21 Nov 2025 | James O. Donnally (Director) | buy | 27,886 | $93,976 at $3.37 |
Sellers outweigh buyers roughly 81 to 1 over twelve months. No open-market purchase by anyone since 2 December 2025.
Authorized: $75.0M standby equity purchase agreement with Yorkville (YA II PN, Ltd.), drawable at the company's discretion | Used: not disclosed in the shelf I read | Remaining: not disclosed in the shelf I read
Shares outstanding by cover-page count: 49,547,673 (Nov 2024), 53,487,294 (Apr 2025), 56,025,554 (Aug 2025), 62,471,971 (Nov 2025), 80,069,319 (Mar 2026), 84,044,748 (May 2026). That is +69.6% in eighteen months, with +28.2% concentrated in the four months from November 2025 to March 2026. The 12 January 2026 placement accounts for a large slice of it: 11,428,572 shares at $3.50, gross proceeds of $40,000,002, net roughly $36.7M, placement agent Titan Partners Group, proceeds earmarked to redeem the outstanding convertible debentures and for working capital. One quarter later the company had consumed $34,031,000 of operating cash.
707,537 shares short at 1.04% of float on 15 August 2025, rising to 8,793,478 at 12.88% by 15 July 2026. A twelvefold increase in eleven months, and the build has been continuous rather than event-driven.
| RSI (14) | 41.9 |
| EMA 20 | $3.77 |
| EMA 50 | $4.53 |
| EMA 200 | $4.84 |
| MACD | -0.500 |
| Signal | -0.577 |
| ATR (14) | $0.43 |
The three moving averages sit in descending order above the price: EMA20 at 3.7659, EMA50 at 4.5256, EMA200 at 4.8381. That is a downtrend with the structure intact, not a stock consolidating after a shock. The last close of $3.42 sits 9.2% under the 20-day and 29.3% under the 200-day. RSI at 41.9 is not oversold, which removes the usual bounce argument. MACD at -0.4999 has crossed marginally above its signal line at -0.5769, the only constructive reading on the board, and a single cross of that size after a 56% decline is noise until price confirms it. ATR of $0.4286 is 12.5% of the share price, so a normal session moves this stock more than a bad quarter moves most large caps. Position sizing has to start from that number. Verified support sits at 2.80, then 2.52, then the 52-week low at 2.36. Verified resistance does not begin until 5.21, which is 52% above the last close. There is nothing structural between $3.42 and $2.80 to lean on.
| Indicator | Value | Signal |
|---|---|---|
| Regime state | risk_on, 57.9% confidence | Defensiveness score 3.3 out of 100 |
| 5-day transition odds | risk_on 48.9%, neutral 27.0%, early risk-off 16.5%, crisis 7.7% | No macro tailwind is required for this thesis |
Regime: risk-on
The tape is not the problem. A risk-on regime is exactly the environment in which a micro-cap with a funding need gets funded rather than left to fail, which is precisely why the equity facility is the base case rather than insolvency. Read the regime as raising the odds of dilution, not of collapse.
One risk dominates and it is arithmetic. $55,367,000 of cash at 31 March against $34,031,000 consumed in the quarter just ended gives 1.6 quarters of cover from that date. Four months and change have since passed. The company has an effective shelf and a $75.0M equity facility sitting ready, which is the reason to expect a raise rather than a failure. Dilution here is not a risk to be weighed against others. It is a schedule.
A micro-cap with an open funding need does not trade on its products. It trades on the terms of its next financing. Every piece of good news from Accelsius or Refinity between now and that financing raises the price at which the company can issue, which is good for the company and neutral to negative for anyone who already owns the shares being diluted. That asymmetry is the whole position. Judge this name on the 13 August cash line first and the venture milestones second.
Data: Short interest rose from 707,537 shares (1.04% of float) at the 15 August 2025 settlement to 8,793,478 (12.876%) at 15 July 2026, across twenty-three consecutive official settlements.
Interpretation: A twelvefold build spread evenly over eleven months is a position being constructed on a thesis, not a reaction to a headline. The thesis is legible from the filings.
History: The build accelerated through the November 2025 to March 2026 window, the same window in which the share count rose 28.2%.
Data: 11,428,572 shares placed at $3.50 on 12 January 2026 for gross proceeds of $40,000,002. The last close is $3.42.
Interpretation: Institutional buyers who funded the January deal are 2.3% underwater seven months later, after the company consumed $34,031,000 of operating cash in the following quarter. Any new issue on the effective shelf has to clear against that reference point.
History: Proceeds were earmarked to redeem the outstanding convertible debentures and for working capital.
Data: Daniel J. Hennessy sold 582,139 shares at $5.52 on 20 April 2026 for $3,213,407, taking his holding from 764,497 to 182,358. He resigned from the board on 29 April 2026, nine days later.
Interpretation: Legal, disclosed and on the record. The sequence is still worth reading in full rather than as two unrelated filings, particularly since his departure is what triggered the audit committee deficiency.
History: He had already sold 438,849 shares between October and December 2025.
| Date | Filing | Issuer | Detail | Signal |
|---|---|---|---|---|
| 18 Mar 2026 | S-3 | Innventure, Inc. | Shelf registering 41,291,719 resale shares plus a $75.0M standby equity purchase agreement; effective 8 April 2026 | The financing channel, live and drawable |
| 14 Jan 2026 | 424B5 | Innventure, Inc. | 11,428,572 shares at $3.50, gross $40,000,002, net ~$36.7M, agent Titan Partners Group | Prior takedown, priced above today |
| 23 Dec 2025 | S-3 | Innventure, Inc. | Preceding shelf, effective 9 January 2026 | The channel used for the January placement |
| 12 Nov 2025 | 8-K 1.01/2.03/3.02 | Innventure, Inc. | New financial obligation plus unregistered sale of equity securities | One of six such 8-Ks since October 2024 |
| 23 Oct 2025 | S-1 | Innventure, Inc. | Registration statement | Third S-1 in twelve months |
| 16 Sep 2025 | 8-K 1.01/2.03/3.02 | Innventure, Inc. | New financial obligation plus unregistered sale of equity securities | Pattern, not incident |
YA II PN, Ltd. (Yorkville) holds 16,309,741 registered resale shares, 23.9% of the float, and is the counterparty to the $75.0M standby equity purchase agreement. Standby facilities of this kind are drawn at a discount to prevailing market prices, which mechanically links each drawdown to downward pressure on the share price and to a larger share count on the next drawdown. That is the structure, stated neutrally; nothing here alleges misconduct by any party.
No trading halt, no compliance flag, no failure-to-deliver threshold listing, and no most-shorted designation at the time of writing. The two 2026 listing-rule notices concerned audit committee composition and were cured on 19 May 2026. The pressure on this equity is structural and fully disclosed in the filings rather than anomalous.
The downtrend is intact below the 20-day at 3.7659, and the first verified support is 18% lower at 2.80. A raise on the effective shelf is the base case rather than the tail case, and equity drawdowns at market price a stock toward its support, not its resistance. The invalidation is clean: a Q2 balance sheet that shows cash comfortably above $25M with the burn rate decelerating, or a reclaim of the 20-day that holds for three sessions, kills this map entirely.
Retail loses money on names like this by buying the product story and paying for it in share count. Set your position size from the ATR of 12.5% of price, decide in advance what the 13 August cash line has to say, and write that number down before the release rather than after it.
This analysis is provided for informational and educational purposes only. It does not constitute financial advice, investment recommendation, or solicitation to buy or sell any security.
Past performance is not indicative of future results. All investments involve risk, including the possible loss of principal. Always conduct your own research and consult a licensed financial advisor before making investment decisions.
Data sourced from real-time market data, Yahoo Finance, SEC EDGAR, and public market data. Accuracy is not guaranteed.